rs587783203
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_139058.3(ARX):āc.625G>Cā(p.Gly209Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000808 in 1,137,997 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_139058.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARX | NM_139058.3 | c.625G>C | p.Gly209Arg | missense_variant | 2/5 | ENST00000379044.5 | NP_620689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARX | ENST00000379044.5 | c.625G>C | p.Gly209Arg | missense_variant | 2/5 | 1 | NM_139058.3 | ENSP00000368332.4 |
Frequencies
GnomAD3 genomes AF: 0.0000366 AC: 4AN: 109388Hom.: 0 Cov.: 23 AF XY: 0.0000927 AC XY: 3AN XY: 32368
GnomAD3 exomes AF: 0.0000613 AC: 5AN: 81504Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 25456
GnomAD4 exome AF: 0.0000856 AC: 88AN: 1028577Hom.: 0 Cov.: 32 AF XY: 0.0000573 AC XY: 19AN XY: 331475
GnomAD4 genome AF: 0.0000366 AC: 4AN: 109420Hom.: 0 Cov.: 23 AF XY: 0.0000926 AC XY: 3AN XY: 32410
ClinVar
Submissions by phenotype
epileptic encephalopathy, early infanitle, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
Intellectual disability, X-linked, with or without seizures, arx-related;C3463992:Developmental and epileptic encephalopathy, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 209 of the ARX protein (p.Gly209Arg). This variant is present in population databases (rs587783203, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ARX-related conditions. ClinVar contains an entry for this variant (Variation ID: 157760). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ARX protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 01, 2024 | See Variant Classification Assertion Criteria. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at